Zivo Bioscience
(ZIVO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,756 | -5,491 | -4,065 | -2,219 | -9,106 |
| Depreciation Amortization | -534 | -334 | 11 | 5 | 1 |
| Accounts payable and accrued liabilities | -905 | -831 | -641 | 176 | 187 |
| Other Working Capital | -394 | -422 | -414 | 187 | 2,669 |
| Other Operating Activity | 3,786 | 2,175 | 2,009 | 800 | 3,661 |
| Operating Cash Flow | $-6,803 | $-4,902 | $-3,100 | $-1,052 | $-2,588 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 191 | N/A | N/A | 191 | 251 |
| Debt Issued | N/A | 191 | 191 | N/A | N/A |
| Debt Repayment | N/A | -191 | -127 | N/A | N/A |
| Common Stock Issued | 17,265 | 17,265 | 15,425 | 1,131 | 2,130 |
| Other Financing Activity | -1,888 | -1,698 | -1,623 | -175 | 0 |
| Financing Cash Flow | $15,567 | $15,567 | $13,866 | $1,146 | $2,380 |
| Beginning Cash Position | 138 | 138 | 138 | 138 | 346 |
| End Cash Position | 8,902 | 10,803 | 10,903 | 232 | 138 |
| Net Cash Flow | $8,764 | $10,666 | $10,765 | $94 | $-208 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,803 | -4,902 | -3,100 | -1,052 | -2,588 |
| Free Cash Flow | -6,803 | -4,902 | -3,100 | -1,052 | -2,588 |